Abstract

BackgroundMorphine, the principal active agent in opium, is not restricted to plants, but is also present in different animal tissues and cell types, including the mammalian brain. In fact, its biosynthetic pathway has been elucidated in a human neural cell line. These data suggest a role for morphine in brain physiology (e.g., neurotransmission), but this hypothesis remains a matter of debate. Recently, using the adrenal neuroendocrine chromaffin cell model, we have shown the presence of morphine-6-glucuronide (M6G) in secretory granules and their secretion products, leading us to propose that these endogenous alkaloids might represent new neuroendocrine factors. Here, we investigate the potential function of endogenous alkaloids in the central nervous system.Methodology and Principal FindingsMicroscopy, molecular biology, electrophysiology, and proteomic tools were applied to human neuroblastoma SH-SY5Y cells (i) to characterize morphine and M6G, and (ii) to demonstrate the presence of the UDP-glucuronyltransferase 2B7 enzyme, which is responsible for the formation of M6G from morphine. We show that morphine is secreted in response to nicotine stimulation via a Ca2+-dependent mechanism involving specific storage and release mechanisms. We also show that morphine and M6G at concentrations as low as 10−10 M are able to evoke specific naloxone-reversible membrane currents, indicating possible autocrine/paracrine regulation in SH-SY5Y cells. Microscopy and proteomic approaches were employed to detect and quantify endogenous morphine in the mouse brain. Morphine is present in the hippocampus, cortex, olfactory bulb, and cerebellum at concentration ranging from 1.45 to 7.5 pmol/g. In the cerebellum, morphine immunoreactivity is localized to GABA basket cells and their termini, which form close contacts on Purkinje cell bodies.Conclusions/SignificanceThe presence of morphine in the brain and its localization in particular areas lead us to conclude that it has a specific function in neuromodulation and/or neurotransmission. Furthermore, its presence in cerebellar basket cell termini suggests that morphine has signaling functions in Purkinje cells that remain to be discovered.

Highlights

  • Morphine is one of the 40 alkaloids present in opium from Papaver somniferum, and is one of the strongest known analgesic compounds [1]

  • We have found that the UGT2B7 enzyme, which converts morphine to M6G, is expressed in these cells

  • Subcellular localization of morphine in SH-SY5Y cells Using laser confocal microcopy, the labeling obtained with an anti-morphine sheep polyclonal antibody was compared to that of chromogranin A (CGA) [15], a specific marker of Large Dense Core (LDC) vesicles [25,26,27,28]

Read more

Summary

Introduction

Morphine is one of the 40 alkaloids present in opium from Papaver somniferum, and is one of the strongest known analgesic compounds [1]. Our group has reported the presence of morphine-6-glucuronide (M6G), previously considered a product of morphine catabolism, in the secretory granules and secreted material of bovine adrenal chromaffin cells In these cells, M6G represents the final product of endogenous alkaloid biosynthesis and is formed through the action of an UDP-glucuronosyltransferase 2B-like enzyme (UGT2B). Secretion of M6G, catecholamines, and PEBP [15] into the blood is likely to occur during stress situations, and could be involved in different stress-modulating or pain-modulating mechanisms via binding to m opioid receptors (MORs), which are present on numerous cell types [16,17,18] Together, all these observations suggest that endogenous alkaloids may represent new neuroendocrine factors [15]. We investigate the potential function of endogenous alkaloids in the central nervous system

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call